Correction to "GSK3 β inhibitor TDZD8 ameliorates brain damage through both ROS scavenging and inhibition of apoptosis in hyperglycemic subarachnoid haemorrhage rats"

Clin Exp Pharmacol Physiol. 2024 Jun;51(6):e13853. doi: 10.1111/1440-1681.13853.NO ABSTRACTPMID:38636943 | DOI:10.1111/1440-1681.13853
Source: Clinical and Experimental Pharmacology and Physiology - Category: Drugs & Pharmacology Source Type: research